APHL’s Policy Program promotes the work of governmental public health laboratories by advocating for a sustainable laboratory network and voicing the impact of federal regulatory rules on public health laboratories.

Regulatory Response Activities

Zika Response

Select Agents

Common Rule

HHS Notice of Proposed Rulemaking to update the federal policies that protect human subjects in federally funded research

Laboratory Developed Tests

FDA Policy Guidance on Oversight of Laboratory Developed Tests

Semantic Interoperability of Laboratory Data

Promoting Semantic Interoperability of Laboratory Data Public Workshop

Pandemic Influenza Preparedness Framework

Antimicrobial Resistance Rapid, Point-of-Care Diagnostic Test Challenge

Request for Comment: Antimicrobial Resistance Rapid, Point-of-Care Diagnostic Test Challenge

Advocacy Letters: 2016

Zika Emergency Funding
FY17 302(b) Federal Appropriations
Toxic Substances Control Act